Audits, Form 10, S-1 Funding, MYFLIX, Investment

New Post Public Reply Private Reply Replies (0) Message Board
speckulater
446
Audits, Form 10, S-1 Funding, MYFLIX, Investment Opportunity




HHSE INVESTOR RELATIONS



Friday, June 14, 2019


INVESTORS ARE ASKING ABOUT HANNOVER HOUSE....


Pictures: Hannover House, MYFLIX Logos


Greetings HHSE Friends & Followers - Last week (during the WALMART Annual Shareholder's Meetings in N.W. Arkansas), HHSE C.E.O. ERIC PARKINSON was asked by quite a few institutional-level investors and funds to provide an update on "what's happening at HHSE..." and more specifically "... is this a GOOD time to accumulate shares?"

As per S.E.C. guidelines, it is not possible to provide a manager's analysis or prognostication to a handful of investors - unless this same information is provided simultaneously via a public forum or disclosure to ALL current and prospective investors. Accordingly, this blog is designed to provide a manager's level analysis and to answer the questions of "what's happening at HHSE" and "is this a GOOD time to accumulate shares?"

These are both relevant and timely questions.

Over the past few years, the Hannover House blogsite (on which this post appears), has concentrated primarily on writing about all of the great-and-amazing things that the company is endeavoring to achieve. So, for those not previously following this Blog, here's a quick bullet point of why many investors and shareholders are bullish on HHSE:

1). HANNOVER HOUSE HAS LONGEVITY - AND IS MULTI-FACETED. Formed in 1993 and operating continuously now for 26-years, Hannover House has longevity and stability at an unprecedented level for an OTC Pinksheets company. Additionally, the company has shown resilience in evolving or refocusing its business models to accommodate the changing media marketplace (from books, to DVDs, to Theatrical, to International and now onto Streaming).


Pictures: Awards, Cannes International Film Festival


2). HANNOVER'S NEW MODEL FOR PURSUING "HIGH-PROFILE" FEATURES - The maturing independent film marketplace now prefers bigger-budgeted films, with top-name stars as opposed to the early DVD years which made micro-budget programming surprisingly profitable. This new model of bigger films is beneficial to Hannover House because it provides operating liquidity and a tremendous "upside potential" without downside risk (as the films are funded through presales and incentives). Additionally, these films become part of a permanent asset base for HHSE.


Pictures: Meltdown, The Legend of Belle Starr, Wildfire


3). HANNOVER'S VENTURE FOR MyFLIX COULD BE ENORMOUS - The in-home digital streaming model is rapidly becoming the dominant form of home-entertainment delivery. Hannover House has been contracted to create and launch a multi-studio streaming site called MyFlix, which combines over 12,000 titles of programming from over 40-supplier studios into a one-stop digital superstore. Think of MyFlix as the "Walmart" of digital streaming. Hannover has the option to acquire MyFlix (for $1) after a successful launch and the satisfaction of corporate actions.


Pictures: CEO, Various MYFLIX


4). HANNOVER'S PENDING S.E.C. REGISTRATION FILING - For the past nine years, Hannover House has been operating as an OTC Pinksheets company. Many investors and funds are prohibited by law or self-governance from investing in "Pinksheet" stocks. Accordingly, the current registration with the S.E.C. (via Form 10), is expected to significantly increase shareholder access to HHSE, and as a result, is expected to have an appreciation impact to the stock value. The HHSE shares would be up-listed to either OTC: QB or OTC: QX. Hannover House is also filing a post Form 10 "S-1 Registration Statement" designed to generate up to $8-mm in operating cash for the company via the direct sale of stock shares at between $.03 and $.08 each... making the current market pricing of the stock ($.0115 approx.) into a bargain opportunity.

5). HANNOVER'S STOCK "PUBLIC FLOAT" IS TIGHTLY CONTROLLED - the vast majority of the HHSE "public-float" stock (over 85%) is controlled by about thirty key shareholders that have made the long-term commitment to hold their shares and to support a move of the stock past the $.10 / share level (or higher). These are sophisticated and substantial traders and investors who recognize that the UPSIDE RUN has not yet happened for Hannover House - and that any one of the key corporate endeavors could trigger an explosive appreciation in stock interest and pricing. This tight control and shareholder commitment has made the stock price very STABLE over the past nine years. While there have been some short-term "peaks" in pricing (and a few, short-term dips), the year-over-year AVERAGE stock price without any of these significant corporate benchmarks has averaged between $.011 and $.028 / share... putting the current stock pricing at the bottom end of the company's historic average trading ranges.


IN SUMMARY...

* The current elimination of balance sheet debts will have a significant and positive impact to the company.

* The registration and up-list opportunities this opens for HHSE will substantially increase shareholder access to the stock.

* Four feature productions are providing overhead and cash flow to Hannover House -and three of these films offer an upside measured (literally) into the tens-of-millions of dollars as being both realistic and obtainable possibilities.

* The MyFlix website and streaming APP has over 40-studio supplier partners (including titles from THREE of the Major Studios). If a site such as Accorn.TV is currently generating over $80-mm per year offering U.K. Television Programming and Urban Films... what can a website and streaming APP like MyFlix generate with more than 12,000 titles, a dozen programming categories and an easily branded name?

These are the principal reasons cited to HHSE managers from key shareholders as to their commitment and enthusiasm for an impressive and solid UPSIDE for Hannover House.


********


BUT, IT'S NOT ALL ROSES FOR HHSE - THERE ARE SOME CHALLENGES...

The path to registration, up-listing and our new business model is not without obstacles. Hannover House has been focusing tremendous effort these past few months on cleaning-up issues relating to the prior business model, or otherwise addressing items with bad optics or perceived risk.

a). LITIGATION MATTERS - Three months ago, there were two "small" and six "significant" litigation matters that the company wanted to address or resolve in support of the Form 10 filing. Responses and resolutions have already been achieved for three of these items. Of the remaining four significant matters (which are comprised of two predatory lenders and two indie producer disputes), two of these issues are being responded to by counsel next week - with the remaining two responses are being handled for the week ending June 28. HHSE has prevailed in two similar disputes with predatory lenders... and HHSE has prevailed in 15 of the 17 total producer disputes that have arisen during the company's 26-year history (during which time, a total of 458-titles have been released, resulting in a producer litigation rate of under 4%, which is less than 1/3rd of the USA Studios average). However, some HHSE shareholders are growing impatient due to the length of time required to adequately address all of these Form 10 related issues.

b). DEBT BURDEN - Even with victories in the resolution of litigation matters, Hannover House continues to carry an uncomfortable amount of debt. While all of these debts are addressed under the Form 10 and S-1 plans, the overall debt burden may still appears onerous to some outsiders or purposeful critics. However, for the past ten years, the company has been able to manage and juggle its payables and debts under very adverse conditions, and there's no circumstance that management anticipates to change this paradigm. In fact, as the litigation matters are being resolved, the company will be able to reallocate cash resources recently (or currently) spent on legal fees to an acceleration of other debt management. Attorney's are expensive... so, we are happy to be experiencing a reduction in these costs.

c). IT'S THE WILD WEST OF DIGITAL STREAMING - At this moment in time, there is a scramble among media companies to stake a claim in the new digital frontier. Except for Amazon Prime, Netflix and Hulu, MOST of the other streaming competitors are "brand" or "genre'" specific (i.e., DISNEY-FOX, CBS ALL ACCESS, HBO NOW, CURIOSITY STREAM). There is no other announced MULTI-STUDIO, MULTI-GENRE' site like MyFlix... but it's likely that eventually there will be similar, one-stop digital superstores. To the victor go the spoils... which is why Hannover House is focused on a strong, proper and FAST launch of MyFlix.

d). BIG, EVENT MOVIES ARE EXPENSIVE... AND PRODUCTION IS A SLOW PROCESS - It would not be fair to write about a new business model for HHSE that is focused in part on the production of major feature films, without disclosing that the production of major features is expensive, difficult and time-consuming. It starts with a solid property... then moves to creative attachments (director and stars), then moves to international presales, co-production ventures and incentive opportunities before the whole package ends up as collateral for a funding credit facility. Then you have to actually SHOOT the movie, edit the film, add sound effects, visual effects, titles, surround-sound mix and other final mastering. It's about 12-to-18 months (under the best of circumstances) from the decision of "let's do this" to a film's opening day at the theatres. BUT, the presales and incentives remove all financial downside, and the substantial ownership in the completed films by HHSE delivers a big upside with these major productions. These films also become permanent film library assets for HHSE.

e). RELIANCE ON PRINCIPAL MANAGERS - There has been some concern that the future success of HHSE is overly dependent upon the continued employment of C.E.O. Eric Parkinson and President Fred Shefte. While it's clear that both individuals are functioning as the locomotives to move these corporate initiatives forward... the 3-1/2 month medical leave-of-absence last fall for Fred Shefte shows that the train keeps rolling even if one of the engineers is temporarily out of commission. As for Parkinson, he owns 43,141,649 Common Stock Shares (with an opportunity to recapture 31,800,000 previously surrendered shares), and his 2,400,000 Preferred Shares may be converted into 24,000,000 Common Stock Shares under a post-registration reclassification. That puts the current market value of the Parkinson shares at $1,246,664, and at the modest PPS forecast of $.08 / share (post registration), the value of Parkinson's HHSE shares could soar to $7.91-mm. Prior to the registration filing, these officer-owned shares are heavily restricted by law from sale, hypothecation, assignment, attachment or any other form transfer... which collectively illustrates the tremendous upside available to C.E.O. Parkinson for the achievement of the baseline goal of S.E.C. registration and up-listing. What will the HHSE stock price be after the MyFlix Launch or after one or more "big" movies gets released?

f). WHAT IF, WHAT IF, WHAT IF? - There's always a potential for unknown factors, acts of God, terrorist attacks, bad federal governance and other such incidents outside of management's control that could impact the best laid plans. The goal of the HHSE managers is to review all activities and likelihoods and to implement the best obtainable business plan for the company. xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx Omitted MUST READ BLOG For Comprehension xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx.


Therefore, we believe that some of the relevant questions that a prospective investor in HHSE needs to think about are:


1). FORM 10 - Will HHSE complete and file its Form 10 Registration Statement (which is the catalyst to up-listing the stock and dramatically expanding investor access)?

2). CLEAN-UP PRIOR BUSINESS MODEL - Will HHSE managers succeed in cleaning-up / eliminating the distractions that occurred as a result of the prior (indie-film DVD) business model that became unprofitable?

3). BIG MOVIES - Will HHSE managers be able to put together all of the pieces required to get a major motion picture off-the-ground?

4). MYFLIX - Will HHSE (through Vodwiz, Inc.) be able to on-board and launch a major consumer streaming site with over 12,000 titles from 40+ suppliers?

5). MANAGEMENT COMMITMENT - With an upside to Parkinson of nearly $8-mm after registration, uplist and the MyFlix launch (and a $4-mm upside to Shefte).... how committed and motivated are the HHSE managers to implementing these corporate initiatives?

*******

Accordingly, while we have answered the question as to
"What's Happening At Hannover House," the answer to the other question, "Is this a Good Time to Accumulate Shares" can only be answered by the individual investor after an analysis of their own risk-adversity and appetite for upside potential. A Dow Jones Indexed Fund is more liquid, but unlikely to experience the tremendous pricing appreciation that is possible with an equity like Hannover House. On the other hand, the endeavors that Hannover is pursuing are significant and difficult... but the historic share price floor has proven to be remarkably stable over the prior nine years. So, we must defer an investment answer to each individual and their circumstances.

But by all means, watch this space!



http://hannoverhousemovies.blogspot.com/2019/...-last.html





Myflix-Image.jpg


Hannover House Inc. (HHSE) Stock Research Links

HHSE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Core Lab's Quarterly Grit: Navigating a Turbulent Market

Updated Category News Views 0

Core Lab's Quarter in Review With the kind of resilience that makes a trader's hands shake ever so slightly less over a coffee, Core Laboratories Inc. heads into the fourth quarter of 2026. This isn't your typical Wall Street story, that's for sure. Watching a solid player like Core navigate the bumpy roads of today's volatile market reminds me of a...

Continue Reading
Wendy's Faces Takeover Bid Amid Strategic Focus Shift

Updated Category News Views 87

Behind the Unsolicited Offer Folks, it looks like Wendy's (NASDAQ:WEN) got itself mixed up in some high-stakes shenanigans. An unsolicited, non-binding proposal slammed into them, courtesy of the Investor Group led by Trian Partners, Flynn Group LP, BlueFive Capital, and Sixth Street Partners, itching to scoop up every last piece of Wendy’s stock they ain't already...

Continue Reading
Seasonal Hiring Booms as Firms Eye Long-Term Talent

Updated Category News Views 114

A Strategic Shift in Seasonal Hiring It ain't just about the holiday rush anymore, folks. Companies are waking up to the idea that seasonal gigs are more than a temporary Band-Aid. This year, nearly 2 out of 5 companies are planning to bring more seasonal folks into the fold compared to last year. That means a good dose of them are looking for longer-term value—like...

Continue Reading
BASIS Bellevue Expands with New K-4 Campus

Updated Category News Views 65

A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...

Continue Reading
Royce Global Trust: Insights on RGT's Performance

Updated Category News Views 80

Analyzing Royce Global Trust's Approach When you dig into the Royce Global Trust portfolio, what emerges is a tapestry woven through decades of grit and determination in the investing world. This closed-end fund, trading under the symbol NYSE: RGT, is no stranger to the ebbs and flows of global markets. With every tick of the clock, speculation dances around this fund's...

Continue Reading
Raleigh's Auction Direct Stresses Oil Changes

Updated Category News Views 50

Keeping Engines Humming in Raleigh There's nothing quite like keeping an engine running like clockwork, especially in a place like Raleigh where folks rely on their rides day in and day out. That's where Auction Direct USA steps in, offering professional oil change services aimed at preserving the performance and reliability of used cars. A simple yet crucial service:...

Continue Reading
Caylent's Strategic Moves Gain Eyeballs in ISG Report

Updated Category News Views 103

Big Moves in the Contact Center Game There’s a buzz in the tech trenches, folks. Caylent just climbed onto the radar with its prominent mention in the 2026 ISG Provider Lens® Amazon Connect Ecosystem Report. Being dubbed a Product Challenger is no small feat when you’re pitted against some of the giants in tech. What’s their edge? An AI-first strategy, of course,...

Continue Reading
Long March Reflections: Lesson of Adaptation Endures

Updated Category News Views 22

Ever stood in a place where history feels so heavy you can almost touch it? That's Lazikou, a gorge in southern Gansu, where ninety years ago, young soldiers of China's Red Army faced a seemingly impassable barrier. Yet, they managed to climb, transform a military retreat into legend, and essentially shape the nation's path ahead. It's a feat that still sends ripples...

Continue Reading
OLX Rolls Out New AI Tools Amid Trust Issues

Updated Category News Views 78

A Grounded Approach to AI-Driven Market Evolution OLX Group's stepping into some turbulent waters, folks. They've dropped two new AI-assisted tools, Agentic Selling and DealFinder, while users are still trying to wrap their heads around trusting AI. Now, don't get me wrong, there's potential here—but the road ahead isn't paved with gold just yet. AI-Powered Tools Ready...

Continue Reading
TransCode Pursues Strategic Moves for TTX-MC138 Value

Updated Category News Views 56

A New Chapter for TransCode? Every once in a while, you find companies taking bold steps that make the market look twice. Today, that’s TransCode Therapeutics (NASDAQ: RNAZ) putting their chips on the table, determined to find the best route forward for their oncology efforts. Now, I’ve seen outfits talk plans without substance, but getting Tungsten Advisors on board...

Continue Reading

Top 5 Most Recently Viewed Articles

Cliquall Enhances Global Access with Language Support Update

Updated Category News Views 176

Cliquall Expands Global Access Through Multi-Language Support In an exciting development, Cliquall has unveiled its multi-language website and customer support system, aimed at enhancing accessibility and inclusivity for traders around the world. This innovative update now supports languages including Simplified Chinese, Traditional Chinese, Japanese, Korean, and English,...

Continue Reading
Understanding Riksbank's Auction Process for Government Bonds

Updated Category News Views 233

Riksbank's Auction Process for Government Bonds The Riksbank, Sweden's central bank, plays a crucial role in managing the country's monetary policy and influences the national economy. One of the key aspects of its operations is the auctioning of government bonds. This process is designed to facilitate the financing of government activities and provide crucial liquidity...

Continue Reading
Sony's IMX742: Revolutionizing Endoscopic Imaging

Updated Category News Views 60

Sony's Bold Move into Medical Tech You wouldn't expect a company like Sony to make waves in the medical field, but there they go again, shaking things up with their latest announcement. Lurking past the shiny consumer electronics, they've got the IMX742, a sensor designed for single-use endoscopes. A humble 1 mm square powerhouse, boasting about 0.51 megapixels of digital...

Continue Reading
Investigating Key Mergers: ACA, APGE, BOLD, GBCS

Updated Category News Views 7

Probing the Potential Pitfalls of Corporate Mergers Well, here's a situation where the lawyers are having a field day. Monteverde & Associates, perched up in the Empire State Building of all places, is nudging investors with a firm elbow as they dig into a quartet of mergers that involve Arcosa, Apogee Therapeutics, Boundless Bio, and Selectis Health. When legal eagles...

Continue Reading
Market Trends: Analyzing Recent Momo Stock Movements and Nvidia

Updated Category News Views 512

Understanding Recent Momo Stock Movements In today's dynamic market, it's crucial to grasp the ongoing trends that could significantly impact investing. Recently, a noticeable sell-off in momo stocks has taken place, influenced by an interplay of expectations and reality. Investors are encouraged to sharpen their focus on these movements and understand their implications....

Continue Reading